[28]
Later, on or about December of 1985, Daiichi determined the absolute configuration of the levofloxacin molecule to be "S". (Hayakawa Affidavit, Ex. BB, p. DAI-0024054, AR, v. 5, Tab 7, p. 1324;
Novopharm
Trial, above at para. 48.)